Vacancy: | FDA: Fellowship in Method Development for Toxic Element Speciation Analysis in Foods and Dietary Supplements |
Posting date: 02.02.2024
Type: | Postdoctoral fellowships |
Description:
A Postdoctoral Research position is currently available at FDA in College Park, MD. The project involves development and validation of a method for chromium speciation analysis in foods and dietary supplements.
*Applications will be reviewed on a rolling-basis.
Anticipated Start Date in June 2024.
The project involves development and validation of a method for
chromium speciation analysis in foods and dietary supplements. The
candidate will learn how to evaluate existing methods for extraction and
quantification of chromium species in a regulatory setting and develop
methods that can meet the objectives of this study. The participant will
receive hands-on training on the use of various sample preparation and
analytical techniques including microwave-assisted sample digestion,
extraction techniques, ICP-MS and HPLC-ICP-MS. The candidate will also
learn method validation procedures to establish the performance of the
developed method to enable assessment of their applicability. The
candidate will conduct laboratory experiments to help evaluate and
validate the analytical procedures under study and collaboration with
the mentor in the preparation of reports and scientific manuscripts. The
method will be used for regulatory or surveillance activities to ensure
the safety of the food supply and accuracy of food and dietary
supplement labeling. This program, administered by ORAU through its contract with the U.S.
Department of Energy to manage the Oak Ridge Institute for Science and
Education, was established through an interagency agreement between DOE
and FDA. The initial appointment is for one year, but
may be renewed upon recommendation of FDA contingent on the availability
of funds. The participant will receive a monthly stipend commensurate
with educational level and experience. Proof of health insurance is
required for participation in this program. The appointment is full-time at FDA in the College Park, Maryland, area. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.
Completion of a successful background investigation by the Office of
Personnel Management is required for an applicant to be on-boarded at
FDA. OPM can complete a background investigation only for individuals,
including non-US Citizens, who have resided in the US for a total of
three of the past five years. FDA Ethics Requirements
If an
ORISE Fellow, to include their spouse and minor children, reports what
is identified as a Significantly Regulated Organization (SRO) or
prohibited investment fund financial interest in any amount, or a
relationship with an SRO, except for spousal employment with an SRO, and
the individual will not voluntarily divest the financial interest or
terminate the relationship, then the individual is not placed at
FDA. For additional requirements, see FDA Ethics for Nonemployee Scientists.
FDA requires ORISE participants to read and sign their FDA Education
and Training Agreement within 30 days of his/her start date, setting
forth the conditions and expectations for his/her educational
appointment at the agency. This agreement covers such topics as the
following:
- Non-employee nature of the ORISE appointment;
- Prohibition on ORISE Fellows performing inherently governmental functions;
- Obligation of ORISE Fellows to convey all necessary rights to the
FDA regarding intellectual property conceived or first reduced to
practice during their fellowship;
- The fact that research materials and laboratory notebooks are the property of the FDA;
- ORISE fellow’s obligation to protect and not to further disclose or use non-public information.
Contact:
|